1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the Natural Killer Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Natural Killer Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Natural Killer Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Natural Killer Cell Lymphomas 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Natural Killer Cell Lymphomas to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Natural Killer Cell Lymphomas to Oncology Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Natural Killer Cell Lymphomas 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Natural Killer Cell Lymphomas Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Kirin Holdings Company, Limited 28
Clinical Trial Overview of Kirin Holdings Company, Limited 28
Takeda Pharmaceutical Company Limited 29
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 29
Seattle Genetics, Inc. 30
Clinical Trial Overview of Seattle Genetics, Inc. 30
Mundipharma International Limited 31
Clinical Trial Overview of Mundipharma International Limited 31
Cell Medica Limited 32
Clinical Trial Overview of Cell Medica Limited 32
Clinical Trial Overview of Top Institutes / Government 33
Fred Hutchinson Cancer Research Center 33
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 33
National Cancer Institute 35
Clinical Trial Overview of National Cancer Institute 35
Samsung Medical Center 36
Clinical Trial Overview of Samsung Medical Center 36
Sun Yat-sen University 37
Clinical Trial Overview of Sun Yat-sen University 37
FUDAN University 38
Clinical Trial Overview of FUDAN University 38
University of Washington 39
Clinical Trial Overview of University of Washington 39
Case Comprehensive Cancer Center 40
Clinical Trial Overview of Case Comprehensive Cancer Center 40
City of Hope National Medical Center 41
Clinical Trial Overview of City of Hope National Medical Center 41
West China Hospital 42
Clinical Trial Overview of West China Hospital 42
NK-cell Tumor Study Group 43
Clinical Trial Overview of NK-cell Tumor Study Group 43
Five Key Clinical Profiles 44
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 71

List of Tables
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials by Region, 2014* 7
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Proportion of Natural Killer Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Natural Killer Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Natural Killer Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Natural Killer Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Natural Killer Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Natural Killer Cell Lymphomas Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Natural Killer Cell Lymphomas Therapeutics, Global, Withdrawn Clinical Trials, 2014* 22
Natural Killer Cell Lymphomas Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Natural Killer Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014* 28
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 29
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2014* 30
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2014* 31
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Medica Limited, 2014* 32
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 33
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 35
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 36
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 37
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014* 38
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 39
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 40
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 41
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2014* 42
Natural Killer Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by NK-cell Tumor Study Group, 2014* 43

List of Figures
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Natural Killer Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Natural Killer Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Natural Killer Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Natural Killer Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Natural Killer Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Natural Killer Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Natural Killer Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Natural Killer Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Pharmacovigilance Market Analysis By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial), By Type Of Service Providers (In House, Contract Outsourcing) And Segment Forecasts To 2020

Pharmacovigilance Market Analysis By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial), By Type Of Service Providers (In House, Contract Outsourcing) And Segment Forecasts To 2020

  • $ 4 700
  • Industry report
  • May 2016
  • by Grand View Research

Global pharmacovigilance market is expected to reach USD 5.51 billion by 2020. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key ...

Global Clinical Trial Support Services Market – 2015-2020

Global Clinical Trial Support Services Market – 2015-2020

  • $ 4 250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global Clinical Trial Support Services Market is estimated to be $ xx billion for the year 2015 to reach $ xx billion by the year 2020. The CAGR with which market is growing is anticipated to be x.x%. ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.